Cellectar Biosciences, Inc. (CLRB) › Operating Cash FlowCellectar Biosciences, Inc. (CLRB) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2010: -$3.38M2011: -$5.97M2016: -$8.28M2017: -$11.02M2018: -$11.44M2019: -$11.69M2020: -$13.93M2021: -$22.57M2022: -$25.22M2023: -$32.38M2024: -$47.58M2025: -$23.12M-$23.12M2010Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$23.12M+51.4%2024-$47.58M-47.0%2023-$32.38M-28.4%2022-$25.22M-11.8%2021-$22.57M-62.0%2020-$13.93M-19.1%2019-$11.69M-2.2%2018-$11.44M-3.8%2017-$11.02M-33.1%2016-$8.28M—2011-$5.97M-76.5%2010-$3.38M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share